Thus, in addition to disrupted endosomal trafficking by MTMR2 inactivation, it is plausible that the reduced PM levels of PtdSer and PI4P further contributes to the demyelination observed in Charcot-Marie-Tooth disease type 4B1. The gene discussed is MTMR2; the disease is Charcot-Marie-Tooth disease type 4B1.